WHO vaccine-preventable diseases: monitoring system. 2019 global summary

Last updated 15-July-2019 (data as of 1-July-2019)
Next overall update Winter 2019
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 11'2401 Infant (under 12 months) mortality rate: 272
GDP / capita (US$): 15'0451 Child (under 5 years) mortality rate: 332

Population data in thousands3

  2018  2017  2016  2015  2014  2000  1990  1980 
Total population 11  11  10  10  10  10  10 
Births
Surviving infants

Number of reported cases

(Click for retrospective incidence data for Nauru)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  300  10 
Mumps
ChartChart
 
Pertussis
ChartChart
  166 
Polio*
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nauru)
Vaccine year result method % card seen                                                
BCG 2006  98  DHS   95  99*  99*  99*  99*  98  93 
DTP1 2006  98  DHS   95  99*  99*  99  98  80  85 
DTP3 2006  89  DHS   95  90  87  97  91  75  44 
IPV1          99  99*  97  91  99* 
HepB_BD          99*  99*  99*  99*  98  98 
HepB3          90  87  97  91  95  58 
Hib3          90  87  97  91  75 
JapEnc         
MCV1          99*  95  98  98  65 
MCV2          94  94  97  96  49 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2006  91  DHS   95  90  87  97  91  75  27 
Rota1         
RotaC         
RCV1          99*  95  98  98  65 
TT2plus          98  57  24 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2020

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nauru)
BCG
ChartChart
  99  99  99  99  99  93  93 
DTP1
ChartChart
  99  99  99  98  99  85  90 
DTP3
ChartChart
  90  87  97  91  95  44  74 
HepB3
ChartChart
  90  87  97  91  95  58 
HepB_BD
ChartChart
  99  99  99  99  99  98 
Hib3
ChartChart
  90  87  97  91  95 
IPV1
  99  99  97  91 
MCV1
ChartChart
  99  95  98  98  98 
MCV2
ChartChart
  94  94  97  96  94 
PCV3
 
Pol3
ChartChart
  90  87  97  91  95  27  74 
RCV1
ChartChart
  99  95  98  98  98 
RotaC
 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2018 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 18 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 14 weeks; Yes
MR 12, 15 months; Yes
OPV 6, 10, 14 week; 18 months; 4 years; Yes
Td 18 months; 4 years; Yes

Immunizaton indicators

Indicator Expected answer 2018  2017  2016  2015  2014  2013  2012 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No    No  No    No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number   14           

System performance

Total Nº districts in country number     14    14   
Nº districts with DTP3 coverage >=80% number      
% of districts with DTP3 coverage >=80% From 0 to 100%             100 
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No    No  No    No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No    No  No    No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100      100       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No    No  No    No 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.